Spesolimab improves patient-reported outcomes in patients with generalized pustular psoriasis: Results from the Effisayil 1 study.

Alexander A Navarini,Jörg C Prinz,Akimichi Morita,Tsen-Fang Tsai, Manuelle-Anne Viguier,Ling Li,Christian Thoma,Mogana Sivalingam,Mark G Lebwohl

Journal of the European Academy of Dermatology and Venereology : JEADV（2023）

引用 4|浏览8

暂无评分

摘要

Patients with a GPP flare treated with spesolimab achieved improvements in PROs by Week 1, which were sustained for 12 weeks, and achieved MCIDs as early as Week 1.

查看译文

关键词

generalized pustular psoriasis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要